Cardiovascular Studies

Clients planning cardiovascular outcomes studies face a variety of challenges related to patient recruitment, study design, conduct, data quality and the ensuing high cost. GCR Consulting offers the strategic development expertise, global access and operational infrastructure to ensure your cardiovascular outcomes studies are of high quality and completed efficiently and on time.

We draw on the extensive expertise of our therapeutically aligned team of medical, safety, scientific, statistical, project management and regulatory experts to provide the optimal strategies for the design and execution of cardiovascular outcomes studies, incorporating the most recent applicable regulatory guidance. From single studies to full development programs, we provide strategic support and oversight at every stage to preserve efficiency, diminish risks and assure that program objectives are met.


Extensive Cardiovascular Outcomes Experience

GCR’s experience includes cardiovascular outcomes research in support of therapies developed to treat cardiovascular disease, including acute coronary syndrome, heart failure, stroke and related diseases such as diabetes, hyperlipidemia / dyslipidemia and obesity.

GCR has conducted studies in the following areas relevant to cardiovascular outcomes studies:

  • More than 100 cardiovascular studies, including 12 large, complex cardiovascular studies
    • Involving 76,000 patients and 79,600 sites
    • 18,200 patients and 1,000 sites across 41 countries in a single trial
  • More than 50 Type 2 diabetes mellitus studies
    • Involving 33,000 patients and 6,400 sites
  • More than 65 critical care studies
    • Involving 10,000 patients and 1,500 sites
    • Including trauma, sepsis and stroke